BE836954A - Nouveaux derives du tryptophane a activite nerveuse centrale renforcee - Google Patents

Nouveaux derives du tryptophane a activite nerveuse centrale renforcee

Info

Publication number
BE836954A
BE836954A BE163017A BE163017A BE836954A BE 836954 A BE836954 A BE 836954A BE 163017 A BE163017 A BE 163017A BE 163017 A BE163017 A BE 163017A BE 836954 A BE836954 A BE 836954A
Authority
BE
Belgium
Prior art keywords
central nervous
nervous activity
tryptophan derivatives
reinforced central
new
Prior art date
Application number
BE163017A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE836954A publication Critical patent/BE836954A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE163017A 1974-12-23 1975-12-22 Nouveaux derives du tryptophane a activite nerveuse centrale renforcee BE836954A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7442505A FR2295746A1 (fr) 1974-12-23 1974-12-23 Nouveaux derives du tryptophane a activite nerveuse centrale renforcee

Publications (1)

Publication Number Publication Date
BE836954A true BE836954A (fr) 1976-04-16

Family

ID=9146520

Family Applications (1)

Application Number Title Priority Date Filing Date
BE163017A BE836954A (fr) 1974-12-23 1975-12-22 Nouveaux derives du tryptophane a activite nerveuse centrale renforcee

Country Status (6)

Country Link
US (1) US4299838A (xx)
BE (1) BE836954A (xx)
DE (1) DE2557497C2 (xx)
ES (1) ES443766A1 (xx)
FR (1) FR2295746A1 (xx)
GB (1) GB1529340A (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484437A4 (en) * 1989-07-27 1994-06-01 Searle & Co Renal-selective prodrugs for the treatment of hypertension
US5939076A (en) * 1997-11-12 1999-08-17 Allocca Techical, Inc. Composition and method for treating or alleviating migraine headaches
WO1999052539A1 (en) * 1998-04-10 1999-10-21 Mayo Foundation For Medical Education And Research Neo-tryptophan
US7087575B2 (en) * 2002-07-18 2006-08-08 Mayo Foundation For Medical Education And Research Treating the effect of nicotine
ES2373649T3 (es) 2002-09-20 2012-02-07 The Trustees Of The University Of Pennsylvania Análogos de compstatina con actividad mejorada.
US7399324B2 (en) * 2004-01-29 2008-07-15 Camovision Of Georgia, Llc Active agent delivery device
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
CN101325963B (zh) 2005-10-08 2016-01-27 博泰迪亚制药公司 用于眼部病症的补体抑制素和其类似物
EP2377877B1 (en) 2005-11-28 2018-03-28 The Trustees Of The University Of Pennsylvania Potent compstatin analogs
US7671025B2 (en) * 2006-02-24 2010-03-02 Sarentis Therapeutics, Inc. Neurotensin receptor agonists and opioid receptor agonists
WO2007114948A2 (en) * 2006-04-04 2007-10-11 The Brigham And Women's Hospital, Inc. Methods and compositions for inhibiting cell death
ES2545775T3 (es) 2007-02-05 2015-09-15 Apellis Pharmaceuticals, Inc. Análogos de compstatina para uso en el tratamiento de afecciones inflamatorias del sistema respiratorio
CN102458438A (zh) 2009-05-01 2012-05-16 宾夕法尼亚州大学理事会 具有肽骨架和c-末端修饰的经修饰补体抑素
WO2012040259A2 (en) 2010-09-23 2012-03-29 The Trustees Of The University Of Pennsylvania Modified compstatin with improved stability and binding properties
CN107050422B (zh) 2011-05-11 2021-11-09 阿佩利斯制药公司 细胞反应性的、长效的或靶向的坎普他汀类似物及其用途
MX363606B (es) 2011-06-22 2019-03-28 Apellis Pharmaceuticals Inc Uso de inhibidores del complemento en trastornos crónicos.
EP2753636B1 (en) 2011-09-07 2019-10-23 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved pharmacokinetic properties
SI3660033T1 (sl) 2012-11-15 2021-09-30 Apellis Pharmaceuticals, Inc. Analogi kompstatina z dolgotrajnim delovanjem in sorodni sestavki in postopki
WO2014152391A1 (en) 2013-03-15 2014-09-25 Apellis Pharmaceuticals, Inc. Cell-penetrating compstatin analogs and uses thereof
US10213476B2 (en) 2014-03-17 2019-02-26 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
RU2770099C2 (ru) 2015-10-07 2022-04-14 Апеллис Фармасьютикалс, Инк. Схемы введения
US11040107B2 (en) 2017-04-07 2021-06-22 Apellis Pharmaceuticals, Inc. Dosing regimens and related compositions and methods
AU2019247467B2 (en) 2018-04-06 2023-01-19 The Trustees Of The University Of Pennsylvania Compstatin analogs with increased solubility and improved pharmacokinetic properties

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2865928A (en) * 1956-08-03 1958-12-23 Du Pont Resolution of n-acyl-dl-tryptophans
GB873777A (en) * 1959-01-26 1961-07-26 Upjohn Co 5-hydroxy-ª--alkyltryptophans
BE791909A (fr) * 1971-11-24 1973-05-24 Beecham Group Ltd Compositions pharmaceutiques contenant du lithium et du tryptophane

Also Published As

Publication number Publication date
DE2557497A1 (de) 1976-06-24
ES443766A1 (es) 1977-04-16
FR2295746B1 (xx) 1978-08-18
DE2557497C2 (de) 1983-11-03
FR2295746A1 (fr) 1976-07-23
US4299838A (en) 1981-11-10
GB1529340A (en) 1978-10-18

Similar Documents

Publication Publication Date Title
FR2295746A1 (fr) Nouveaux derives du tryptophane a activite nerveuse centrale renforcee
FR2326181A1 (fr) Nouveaux derives benzhydrylsulfinyle
BE817826A (fr) Nouveaux derives de la phenylethylamine
FR2329270A1 (fr) Nouveaux composes a activite anti-fertilite
BE787941A (fr) Nouveaux derives d'oxazoline a activite anti-inflammatoire
FR2326198A1 (fr) Nouveaux steroides a activite erythropoietique
BE824579A (fr) Nouveaux amides a activite pharmacologique
BE814617A (fr) Nouveaux derives de phenylethanolamine a activite pharmacoleogique
BE821418A (fr) Nouveaux derives thiazoliques
BE819749A (fr) Nouveaux derives du benzoxoazole utilisables
FR2329263A1 (fr) Derives du naphtalene
BE846805A (fr) Nouveaux steroides a activite erythropoietique
BE852457A (fr) Nouveaux derives 17-spirosultines
BE808544A (fr) Derives du benzimidazole a substitution basique
BE795265A (fr) Nouveaux derives de quinoleine a activite pharmacologique
BE825075A (fr) Nouveaux derives de la 1,2,4-oxdiazoline-5-one a activite fongicide
BE816566A (fr) Nouveaux derives cyclopentaniques
BE849388A (fr) Nouveaux derives de la spermine a activite bacteriostatique
BE819283A (fr) Nouveaux derives du thiazol 5-methanol
BE815565A (fr) Derives du benzimidazole
FR2278324A1 (fr) Nouveaux derives du paracetamol
BE820723A (fr) Nouveaux derives pyridiques
BE810400A (fr) Nouveaux derives caphalosporaniques
FR2309218A1 (fr) Nouveaux derives de benzobicyclononene a activite anorexiante
BE817377A (fr) Nouveaux thiocarbamates a activite herbicide

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: LES LABORATOIRES MERAM

Effective date: 19881231